Abstract
Impairment of hearing is the most common sensory deficit in human populations. Most cases of human deafness are hereditary. Mutations in many different genes can affect the complex process of hearing. The mouse is an excellent model for studies of these hearing disorders because the anatomy, function, and hereditary abnormalities of the ear have been shown to be similar in both humans and mice. More than 100 spontaneous, chemically-induced, and genetically engineered mouse mutations have been discovered with hearing impairment many of these provide valuable models for both non-syndromic and syndromic forms of human deafness. So far, a total of 64 loci for human non-syndromic hearing impairment have been mapped, the genes responsible for 20 have been identified, and mouse models are available for 8 of these genes. More than 400 human syndromes have been described with associated hearing impairment, and about 80 genes have been identified. Mutations of homologous genes in the mouse have provided models for many of these syndromes. Studies of human hearing disorders and their mouse counterparts have contributed much to our understanding of the hearing process. For example, they have identified molecules (unconventional myosins, espins, and cadherins) that are important for the proper organization of hair cell stereocilia, ion transport and gap junction proteins that regulate endocochlear ion concentrations, and extracellular matrix proteins that compose acellular membranes important in auditory transduction. Genetically diverse inbred strains of mice provide models of age-related and noise-induced hearing loss and also provide a means to discover modifier genes by assessing mutant phenotypes on different strain backgrounds. With the new human and mouse genome initiatives now underway, the mouse will become an even more important animal model for hearing research.
Keywords: human hearing disorder, hereditary deafness, spontaneous mutation, genetically engineered, non syndromic, modifier genes
Current Genomics
Title: Mouse Models of Human Hearing Disorders
Volume: 2 Issue: 1
Author(s): Kenneth R. Johnson
Affiliation:
Keywords: human hearing disorder, hereditary deafness, spontaneous mutation, genetically engineered, non syndromic, modifier genes
Abstract: Impairment of hearing is the most common sensory deficit in human populations. Most cases of human deafness are hereditary. Mutations in many different genes can affect the complex process of hearing. The mouse is an excellent model for studies of these hearing disorders because the anatomy, function, and hereditary abnormalities of the ear have been shown to be similar in both humans and mice. More than 100 spontaneous, chemically-induced, and genetically engineered mouse mutations have been discovered with hearing impairment many of these provide valuable models for both non-syndromic and syndromic forms of human deafness. So far, a total of 64 loci for human non-syndromic hearing impairment have been mapped, the genes responsible for 20 have been identified, and mouse models are available for 8 of these genes. More than 400 human syndromes have been described with associated hearing impairment, and about 80 genes have been identified. Mutations of homologous genes in the mouse have provided models for many of these syndromes. Studies of human hearing disorders and their mouse counterparts have contributed much to our understanding of the hearing process. For example, they have identified molecules (unconventional myosins, espins, and cadherins) that are important for the proper organization of hair cell stereocilia, ion transport and gap junction proteins that regulate endocochlear ion concentrations, and extracellular matrix proteins that compose acellular membranes important in auditory transduction. Genetically diverse inbred strains of mice provide models of age-related and noise-induced hearing loss and also provide a means to discover modifier genes by assessing mutant phenotypes on different strain backgrounds. With the new human and mouse genome initiatives now underway, the mouse will become an even more important animal model for hearing research.
Export Options
About this article
Cite this article as:
Johnson R. Kenneth, Mouse Models of Human Hearing Disorders, Current Genomics 2001; 2 (1) . https://dx.doi.org/10.2174/1389202013351156
DOI https://dx.doi.org/10.2174/1389202013351156 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sudden Unexplained Death in Infancy and Long QT Syndrome
Current Pediatric Reviews Galectins: Major Signaling Modulators Inside and Outside the Cell
Current Molecular Medicine Functions of Fukutin, a Gene Responsible for Fukuyama Type Congenital Muscular Dystrophy, in Neuromuscular System and Other Somatic Organs
Central Nervous System Agents in Medicinal Chemistry Perinatal Gene Transfer to the Liver
Current Pharmaceutical Design Functional Null Mutations in the Gonosomal Homologue Gene TBL1Y are Associated with Non-Syndromic Coarctation of the Aorta
Current Molecular Medicine The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress
Current Neuropharmacology Experimental Antiarrhythmic Targets: CaMKII Inhibition – Ready for Clinical Evaluation?
Current Medicinal Chemistry Pediatrics for Disability: A Comprehensive Approach to Children with Syndromic Psychomotor Delay
Current Pediatric Reviews ADP Receptors-Targets for Developing Antithrombotic Agents
Current Pharmaceutical Design Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Urinary Steroids Measured by Modern Separation Techniques and Applied as Biomarkers in Stress Studies
Current Pharmaceutical Analysis A Proposal----The Renal Kallikrein-Kinin System as a Compensating System for Salt Accumulation after Excess Salt Intake
Current Hypertension Reviews Rational Autologous Cell Sources For Therapy of Heart Failure - Vehicles and Targets For Gene and RNA Therapies
Current Gene Therapy Patient-Specific Induced Pluripotent Stem Cell Models in Mitochondrial Diseases
Current Stem Cell Research & Therapy Novel Targets for Cardiac Antiarrhythmic Drug Development
Current Pharmaceutical Design Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease
Reviews on Recent Clinical Trials New Approaches to Develop Anti-Staphylococcal Agents
Current Medicinal Chemistry - Anti-Infective Agents Prevalence of Congenital Heart Disease among Children in Khorramabad (West of Iran)
Cardiovascular & Hematological Disorders-Drug Targets Patent Landscape of Countermeasures Against Smallpox and Estimation of Grant Attraction Capability Through Patent Landscape Data
Recent Patents on Anti-Infective Drug Discovery